CHUGAI PHARMACEUTICAL CO., LTD. Logo

CHUGAI PHARMACEUTICAL CO., LTD.

A research-driven pharmaceutical company developing innovative medical products.

4519 | T

Overview

Corporate Details

ISIN(s):
JP3519400000
LEI:
Country:
Japan
Address:
北区浮間五丁目5番1号

Description

Chugai Pharmaceutical Co., Ltd. is a research and development-driven pharmaceutical company dedicated to creating innovative medical products to address unmet medical needs. As a member of the Roche Group, Chugai leverages its advanced expertise in biotechnology and science to develop novel treatments, establishing a leading position in therapeutic antibodies. The company's strategy emphasizes a shift towards discovery research and early clinical development, the integration of digital technologies, and open innovation through external partnerships. Its core therapeutic areas include oncology, rheumatology, and haemophilia, where it provides biopharmaceuticals and molecular targeted therapies to patients.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-03-10 07:26
確認書
Japanese 9.6 KB
2023-03-10 07:22
確認書
Japanese 9.6 KB
2023-03-10 07:15
訂正有価証券報告書-第111期(2021/01/01-2021/12/31)
Japanese 1.3 MB
2023-03-10 07:13
訂正有価証券報告書-第110期(2020/01/01-2020/12/31)
Japanese 1.3 MB
2023-03-10 07:11
訂正有価証券報告書-第109期(2019/01/01-2019/12/31)
Japanese 1.0 MB
2023-03-10 07:10
訂正有価証券報告書-第108期(2018/01/01-2018/12/31)
Japanese 860.6 KB
2023-03-10 07:08
訂正有価証券報告書-第107期(2017/01/01-2017/12/31)
Japanese 833.3 KB
2022-10-25 08:14
確認書
Japanese 9.6 KB
2022-10-25 08:11
四半期報告書-第112期第3四半期(令和4年7月1日-令和4年9月30日)
Japanese 337.0 KB
2022-07-22 08:07
四半期報告書-第112期第2四半期(令和4年4月1日-令和4年6月30日)
Japanese 342.2 KB
2022-04-26 08:05
四半期報告書-第112期第1四半期(令和4年1月1日-令和4年3月31日)
Japanese 290.4 KB
2022-03-30 09:15
確認書
Japanese 9.6 KB
2022-03-30 09:08
訂正有価証券報告書-第111期(令和3年1月1日-令和3年12月31日)
Japanese 1.3 MB
2022-03-29 09:17
内部統制報告書-第111期(令和3年1月1日-令和3年12月31日)
Japanese 24.9 KB
2022-03-29 09:12
確認書
Japanese 9.6 KB

Automate Your Workflow. Get a real-time feed of all CHUGAI PHARMACEUTICAL CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CHUGAI PHARMACEUTICAL CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CHUGAI PHARMACEUTICAL CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Bioversys N Logo
Clinical-stage biopharma developing antibacterial therapies for antimicrobial resistance.
Switzerland
BIOV
BIOVIE INC. Logo
Develops drug therapies for neurological disorders and advanced liver disease.
United States of America
BIVI
BioXcel Therapeutics, Inc. Logo
Biopharmaceutical company using AI to develop drugs for neuroscience and immuno-oncology.
United States of America
BTAI
Black Diamond Therapeutics, Inc. Logo
Develops precision oncology therapies targeting families of oncogenic mutations.
United States of America
BDTX
BL Pharmtech Corp. Logo
Researches, develops, and sells health foods, supplements, and pharmaceuticals.
South Korea
065170
BNC Korea Co, Ltd Logo
Develops hyaluronic acid-based dermal fillers and botulinum toxin injectables.
South Korea
256840
Boditech Med Inc. Logo
Develops, manufactures, and distributes in-vitro diagnostic (IVD) solutions.
South Korea
206640
BOIRON Logo
A family-owned pharmaceutical laboratory and a world leader in homeopathic medicines.
France
BOI
Manufactures specialty ingredients for the food, pharmaceutical, and cosmetic industries.
South Korea
002760
Bolt Biotherapeutics, Inc. Logo
Clinical-stage biotech developing immuno-oncology therapies using the innate immune system.
United States of America
BOLT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.